On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

Figure 2: EXT1-expressing cell lines synthesize a heparan-sulfate glycosaminoglycan. Western blots of EXT1myc isolated from transfected Chinese hamster ovary (CHO) cells revealed two forms of ...